Oscar Bukstein, MD, MPH,
Associate Professor of Psychiatry.
Dr. Bukstein is the Medical Director of the Child and
Adolescent Chronic Treatment and Intervention Service of Allegheny County,
PA, which includes the city of Pittsburgh as well as the Medical Director
of the Child and Parent Behavior Clinic Outpatient and Partial
Hospitalization Programs at WPIC. Dr. Bukstein is conducting a Pilot
Project entitled “Development of Alcohol Abuse in Adolescents and
Preadolescents with Early Age Onset Conduct Disorder”. He is involved in a
study entitled “Long-Term Functioning and Alcohol Treatment, and Lapse and
Relapse in Adolescents”. Dr. Bukstein currently conducts two clinical
trials of pharmacological agents and psychosocial interventions in
patients with comorbid psychiatric and substance use disorders.
Tammy Chung, Ph.D.,
Assistant Professor of Psychiatry and
Dr. Chung's research interests include the classification and longitudinal
course of adolescent-onset substance-related problems. NIAAA-funded
research projects include improving the assessment of substance abuse and
dependence in youth and examining predictors of change in the clinical
course among adolescents who have been treated for substance-related
problems. She is Co-Investigator on a NIDA-funded longitudinal study of
four cohorts (Pittsburgh Girls Study) that is investigating developmental
precursors to girls’ substance use. She has special interest in using
novel statistical methods (e.g., latent transition analysis, item response
theory) to study the classification and course of substance use and
related problems in youth. Dr. Chung teaches the course on methodological
and assessment issues in psychiatric epidemiology, which addresses
reliable and valid measurement of alcohol use disorders.
PhD, MD, Associate Professor of Psychiatry and Pharmaceutical Sciences.
conducts studies on etiology, characteristics, course, treatment and
outcomes of adolescent substance use disorders through the Center for
Education and Drug Abuse Research (CEDAR) and the Pittsburgh Adolescent
Alcohol Research Center (PAARC). Dr. Clark served as PAARC PI and
Director. This program is currently funded by NIAAA and NIDA though four
R01s, an R21, and five K awards to PAARC faculty. He is also supported by
an NIAAA K02. His program of research applies an integrated array of
scientific methods for determining the causal relation among alcohol
use and other mental disorders during adolescence. These methods include
advanced statistical modeling techniques for longitudinal data, molecular
genetics, and neuroimaging studies. Dr. Clark’s work combines the basic
and clinical sciences as he was recently funded by NIAAA to examine
frontal white matter organization using diffusion tensor imaging as it
relates to executive functioning in adolescent alcohol use.
Jack R. Cornelius, MD, MPH,
Professor of Psychiatry and Pharmaceutical Sciences.
Dr. Cornelius is board
certified in Psychiatry and in Addiction Medicine. He received an MPH
degree in Epidemiology at the GSPH at the University of Pittsburgh in
conjunction with the completion of two postdoctoral fellowships sponsored
by NIAAA and NIMH. He has 25 years of clinical experience in evaluating
and treating patients with psychiatric conditions and alcohol use
disorders. He is the PI on two current NIAAA R01 grants, the PI of a NIAAA
K award, the PI of a current NIDA R01 grant, the Scientific Director of a
VA Center grant, the Co-Scientific Director of the Pittsburgh node of the
NIDA Clinical Trials Network, and the Director of the Clinical Core of the
CEDAR center grant. He has authored or co-authored over 100 peer-reviewed
articles and 12 book chapters. He serves on NIAAA and NIDA IRG’s and
reviews grants for the American Foundation of Suicide Prevention.
John Donovan, Ph.D.,
Associate Professor of Psychiatry and Epidemiology.
Dr. Donovan is well known for his work on problem behavior
in adolescence, including problem drinking, illicit drug use, delinquency,
and sexual behavior. His current NIAAA-funded research is on the
development of risk factors for drinking and of initiation and escalation
of drinking from middle childhood through middle adolescence. He was
Scientific Director of the PAARC and has been the recipient of a Research
Scientist Development Award (K02) from NIAAA. He is currently on the
Steering Committee for NIAAA’s Underage Drinking Initiative, and chaired
the epidemiology and prevention grant review committee for NIAAA. He has
collected data on eight large-scale population samples of adolescents and
young adults, four of which are longitudinal, two of which are national
Cynthia Larkby, Ph.D.,
Assistant Professor of Psychiatry and Epidemiology. Dr.
Larkby’s research focuses on the relations among childhood abuse,
environmental factors, posttraumatic stress disorder, and subsequent
alcohol use and problem drinking. Her study is one of the five studies in
the MHPCD project. Dr. Larkby works closely with Drs. Cornelius, Day, and
Richardson and provides expertise in areas of depression, PTSD, and child
growth factors. In addition, Dr. Larkby was a co-investigator on an
intervention study of pregnant women to prevent prenatal alcohol use. She
worked with Dr. Kevin Kraemer on this study. Her research examines the
relationship of lifetime and current exposure to childhood physical and
sexual maltreatment and other traumatic events to alcohol and other
Brooke Molina, PhD,
Associate Professor of
Psychiatry and Psychology.
Dr. Molina’s research
activities are in the areas of drug and alcohol abuse and
disruptive behavior disorders with an emphasis on
Attention-Deficit/Hyperactivity Disorder (ADHD) as a risk factor. She is
funded by NIAAA and NIDA to study the link between ADHD, alcohol abuse,
and drug abuse in a longitudinal study of children. She is a PI on the
NIMH-sponsored multi-site study of the children who were in the Multimodal
Treatment of ADHD project.
with Dr. Donovan to study peer- and family-based predictors of early
alcohol use. Across these studies, specific areas of inquiry are the
extent of ADHD risk for drug and alcohol abuse, the mechanisms that may
explain this risk and methodological factors that may affect the
expression of risk.
Gale A. Richardson, PhD,
Associate Professor of Psychiatry and Epidemiology.
Dr. Richardson is trained as a Life-Span Developmental
Psychologist. She is a senior investigator in the MHPCD Project. She is
the PI of a study of the long-term effects of cocaine use during
pregnancy. She is also a Co-Investigator of studies of prenatal alcohol,
marijuana, and tobacco exposures. Dr. Richardson is the Director of the
Psychiatric Epidemiology Training program and also teaches a course on the
Epidemiology of Child Psychiatric Disorders, which is part of the
curriculum available to all trainees.
Ralph Tarter, PhD,
Pharmaceutical Sciences, Psychiatry, and Psychology.
Dr. Tarter is the PI of the Center for Education and Drug Abuse Research
(CEDAR). This P-50 center grant is a longitudinal family-based study aimed
at determining the etiological mechanisms and pathways to a drug use
disorder with or without alcohol use disorder. Dr. Tarter's research
focuses on the neurobehavioral risk factors associated with the risk for
alcoholism and other substance dependence. Dr. Tarter is a
neuropsychologist and is well known for his studies of the effects of
alcohol use on neurocognitive processes and the neurodevelopmental
antecedents of substance abuse.
Willford, Ph.D., Assistant Professor of Psychiatry
Dr. Willford's research focuses on the neurobiological mechanisms
underlying the effects of prenatal substance exposure on cognitive
development. She is the PI of a study using fMRI to elucidate the effects
of prenatal alcohol exposure on response inhibition and cognitive control
in young adults. Her areas of expertise include neuroimaging, cognitive
neuroscience, neuropsychological testing, and behavioral teratology. Dr.
Willford coordinates the weekly seminar on research methodology and
statistics for all trainees.